Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...

The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...

Thanks to a pioneering genetic testing pilot at Doncaster and Bassetlaw Teaching Hospitals (DBTH), 130 stroke patients have ...

Researchers at the University of Maryland identified a potential link between early-onset ischemic stroke and a genetic ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

With the recent report of increase in stroke cases observed after this holiday season by the Department of Health (DOH)1, ...

Discover the critical health markers that can help prevent stroke if you have a family history, plus advice on monitoring ...

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Ascension Wisconsin recently honored Racine paramedics and the Ascension All Saints Hospital Emergency Department for their ...